Clinical Trial Update: Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients [Phase 2]

View source ↗

Summary

A phase 2 trial reports on prolonging the interval between INR monitoring in stable patients on warfarin, with completion and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Valve Diseases

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Atrial Fibrillation, Heart Valve Diseases | Phase 2 | Status: COMPLETED | Results posted: 2018-08-22